NCT01461109View on ClinicalTrials.gov

Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

May 31, 2014

Conditions
Parkinson DiseaseAlzheimer Disease
Interventions
DRUG

[18F] CFPyPB

Each subject will receive a bolus injection targeted to be 5 mCi and not to exceed 5.5 mCi (not \>10% of 5 mCi limit) of \[18F\]CFPyPB or 5 μg of CFPyPB (whichever is greatest).

Trial Locations (1)

06510

Institute_Neurodegenerative_Disorders, New Haven

All Listed Sponsors
lead

Institute for Neurodegenerative Disorders

OTHER

NCT01461109 - Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls | Biotech Hunter | Biotech Hunter